CD44 and cancer: RP11‐89 was significantly correlated with the expression of CD44, CD70 and LAGLS9 in pan‐cancers (Figure 8A) and was significantly associated with the abundance of activated CD4 T cells, activated CD8 T cells and effector memory CD4 T cells in pan‐cancers (Figure 8B).